Biotechnology

Techseriesinsight > Blog > News > Biotechnology

August 4, 2026
Business Wire
Biotechnology, News

QuantHealth Raises $45 Million Series B, led by Qumra Capital, to Accelerate Simulation-First Clinical Trial Development

QuantHealth, a global leader in AI-driven clinical trial simulation, today announced a $45 million Series B. The round was led by Qumra Capital, with support from additional investors, including Pitango...

August 3, 2026
PRNewswire
Biotechnology, News

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of...

July 30, 2026
PRNewswire
Biotechnology, News

Seoul National University of Science and Technology Researchers Show Perilla Oil Improves Blood Circulation and Coagulation in Healthy Smokers

Cardiovascular disease (CVD) is a leading cause of death worldwide and the second leading cause in South Korea, with incidence continuing to rise. This growing burden affects public health...

July 29, 2026
PRNewswire
Biotechnology, News

10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

The life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Lausanne University Hospital (CHUV), one of Switzerland’s leading academic medical...

July 24, 2026
PRNewswire
Biotechnology, News

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit...

July 24, 2026
Business Wire
Biotechnology, News

Vir Biotechnology Announces Chief Financial Officer Transition

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Brent Sabatini, Senior Vice President and Chief Accounting Officer, has been appointed Interim Principal Financial Officer, effective July 23. Jason O’Byrne...

July 23, 2026
PRNewswire
Biotechnology, News

Evoworks Bio Selected for BARDA-Backed VANGUARD Program to Demonstrate Rapid, Scalable Production of Critical Biologics

Evoworks Bio today announced its platform technology has been selected for BioTools Innovator VANGUARD Funding, powered by BioTools Innovator (BTI) in partnership with the Biomedical Advanced Research and Development...

July 22, 2026
PRNewswire
Biotechnology, News

DEMETRA ANNOUNCES A STRATEGIC COLLABORATION WITH MASMEC BIOMED

Demetra Holding announces a strategic collaboration with Masmec Biomed, an Italian company specialized in the development of advanced surgical navigation systems, AI, and high-complexity medical technologies. The collaboration stems...

July 22, 2026
Business Wire
Biotechnology, News

Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study

Natera, Inc, a global leader in cell-free DNA and precision medicine, today announced the publication of results from a prospective, multicenter study in Merkel cell carcinoma (MCC) published in JAMA Dermatology. The...

July 21, 2026
PRNewswire
Biotechnology, News

Ebix Appoints Mary Beth Titsworth as Vice President for its Health and Wellness Vertical

Ebix today announced the appointment of Mary Beth Titsworth as Vice President, Health Content, for its Health and Wellness vertical. In this role, Titsworth will lead the growth strategy...